International Journal of Hematology and Oncology 2022, Vol 32, Num 2 Page(s): 093-101
Real-World Data of Nivolumab and Pembrolizumab in Platinum Refractory Advanced Non-Small Cell Lung Cancer: Potential Practical Predictors of Treatment

Omer DIKER1,2, Polat OLGUN1,2

1Near East University, Faculty of Medicine, Department of Medical Oncology, CYPRUS
2Dr. Burhan Nalbantoglu State Hospital, Department of Medical Oncology, Nicosia, CYPRUS